OMER

Omeros Corporation (OMER)

About Omeros Corporation (OMER)

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Details

Daily high
$12.83
Daily low
$10.08
Price at open
$10.08
52 Week High
$13.60
52 Week Low
$2.61
Market cap
597.5M
Dividend yield
0.00%
Volume
2.5M
Avg. volume
1.2M
P/E ratio
-4.48

Omeros Corporation News

Details

Daily high
$12.83
Daily low
$10.08
Price at open
$10.08
52 Week High
$13.60
52 Week Low
$2.61
Market cap
597.5M
Dividend yield
0.00%
Volume
2.5M
Avg. volume
1.2M
P/E ratio
-4.48